Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Circulating microRNA alternations in primary hyperuricemia and gout

Fig. 2

Difference in miR-17 (A), miR-18a (B), miR-30c (C), miR-142 (D), and miR-223 (E) plasma levels in patients with hyperuricemia, gout, or during gout attack compared to normouricemic controls. P-values of the Tukey post hoc pairwise comparisons, based on an ANOVA model with log-transformed delta cycle threshold values of listed miRNAs. These miRNAs were significantly increased in studied groups compared to normouricemic controls

Back to article page